Literature DB >> 11812762

Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes.

M Luiza Caramori1, Youngki Kim, Chunmei Huang, Alfred J Fish, Stephen S Rich, Michael E Miller, Greg Russell, Michael Mauer.   

Abstract

This study was designed to elucidate the cellular basis of risk of or protection from nephropathy in patients with type 1 diabetes. Entry criteria included diabetes duration of > or =8 years (mean duration, 22.5 years) and glomerular filtration rate (GFR) >30 ml x min(-1) x 1.73 m(-2). Patients were classified, on the basis of the estimated rate of mesangial expansion, as "fast-track" (upper quintile) or "slow-track" (lower quintile). A total of 88 patients were normoalbuminuric, 17 were microalbuminuric, and 19 were proteinuric. All three groups had increased glomerular basement membrane (GBM) width and mesangial fractional volume [Vv(Mes/glom)], with increasing severity from normoalbuminuria to microalbuminuria to proteinuria but with considerable overlap among groups. Vv(Mes/glom) (r = 0.75, P < 0.001) and GBM width (r = 0.63, P < 0.001) correlated with albumin excretion rate (AER), whereas surface density of peripheral GBM per glomerulus [Sv(PGBM/glom)] (r = 0.50, P < 0.001) and Vv(Mes/glom) (r = -0.48, P < 0.001) correlated with GFR. Vv(Mes/glom) and GBM width together explained 59% of AER variability. GFR was predicted by Sv(PGBM/glom), AER, and sex. Fast-track patients had worse glycemic control, higher AER, lower GFR, more hypertension and retinopathy, and, as expected, worse glomerular lesions than slow-track patients. Thus, there are strong relationships between glomerular structure and renal function across the spectrum of AER, but there is considerable structural overlap among AER categories. Given that normoalbuminuric patients may have advanced glomerulopathy, the selection of slow-track patients based on glomerular structure may better identify protected patients than AER alone.

Entities:  

Mesh:

Year:  2002        PMID: 11812762     DOI: 10.2337/diabetes.51.2.506

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  60 in total

Review 1.  Genome-wide association studies of chronic kidney disease: what have we learned?

Authors:  Conall M O'Seaghdha; Caroline S Fox
Journal:  Nat Rev Nephrol       Date:  2011-12-06       Impact factor: 28.314

2.  Cellular basis of diabetic nephropathy: III. In vitro GLUT1 mRNA expression and risk of diabetic nephropathy in type 1 diabetic patients.

Authors:  C Huang; Y Kim; M L Caramori; A J Fish; S S Rich; M E Miller; G B Russell; M Mauer
Journal:  Diabetologia       Date:  2004-10-22       Impact factor: 10.122

3.  Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.

Authors:  Gudeta D Fufaa; E Jennifer Weil; Robert G Nelson; Robert L Hanson; William C Knowler; Brad H Rovin; Haifeng Wu; Jon B Klein; Theodore E Mifflin; Harold I Feldman; Ramachandran S Vasan; Paul L Kimmel; John W Kusek; Michael Mauer
Journal:  Nephrol Dial Transplant       Date:  2015-02-03       Impact factor: 5.992

4.  Acute kidney injury in a diabetic haemophiliac: one step at a time.

Authors:  Mohammed Mahdi Althaf; Maged Hassan Hussein; Mohamed Said Abdelsalam; Sadiq Mohammed Amer
Journal:  BMJ Case Rep       Date:  2014-05-08

Review 5.  Early detection of diabetic kidney disease: Present limitations and future perspectives.

Authors:  Chih-Hung Lin; Yi-Cheng Chang; Lee-Ming Chuang
Journal:  World J Diabetes       Date:  2016-07-25

Review 6.  The natural progression of kidney injury in young type 1 diabetic patients.

Authors:  Julia M Steinke
Journal:  Curr Diab Rep       Date:  2009-12       Impact factor: 4.810

Review 7.  Morphologic features of declining renal function in type 1 diabetes.

Authors:  Behzad Najafian; Michael Mauer
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

8.  Improvement of renal oxidative stress markers after ozone administration in diabetic nephropathy in rats.

Authors:  Mohamed D Morsy; Waleed N Hassan; Sherif I Zalat
Journal:  Diabetol Metab Syndr       Date:  2010-05-13       Impact factor: 3.320

9.  Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy.

Authors:  Marcus G Pezzolesi; Pisut Katavetin; Masahiko Kure; G David Poznik; Jan Skupien; Josyf C Mychaleckyj; Stephen S Rich; James H Warram; Andrzej S Krolewski
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

10.  Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT).

Authors: 
Journal:  BMC Pediatr       Date:  2009-12-17       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.